LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

LLY

1,136.75

-1.98%↓

JNJ

240.59

+1.09%↑

ABBV

227.54

+1.25%↑

UNH

408.27

+0.76%↑

MRK

119.2

-1.13%↓

Search

Corvus Pharmaceuticals Inc

Uždarymo kaina

11.91 3.03

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

11.88

Max

12.1

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-1.4M

-14M

Pelnas, tenkantis vienai akcijai

-0.15

Darbuotojai

37

EBITDA

-2.7M

-15M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+164.88% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-06

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-410M

938M

Ankstesnė atidarymo kaina

8.88

Ankstesnė uždarymo kaina

11.91

Corvus Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-06-14 23:51; UTC

Builder confidence in U.S. housing market shows cautious optimism with June NAHB Index forecast at 37, amid ongoing economic uncertainties and Canadian policy announcements influencing North American trends.

2026-06-14 23:51; UTC

Correlated Moves

Cardano is rising sharply in the current session, reflecting a broader positive trend in the cryptocurrency market amid improving sentiment and recent volatility.

2026-06-14 23:51; UTC

Correlated Moves

XRP is gaining in the current session, influenced by Bitcoin's rise. The asset remains higher since Saturday's close amid notable volatility.

2026-06-14 23:51; UTC

Macro News
Correlated Moves

Bitcoin is trading higher, supported by a U.S.-Iran peace deal easing oil prices and boosting market sentiment. The cryptocurrency has gained since Saturday's close.

2026-06-14 23:41; UTC

Geopolitical tensions and rising job cuts raise economic concerns as the Bank of Japan prepares to slightly increase interest rates, while U.S. stock markets show resilience amid optimism over potential peace negotiations.

2026-06-14 23:41; UTC

Geopolitical tensions and anticipated Bank of Japan rate hike influence market sentiment as U.S. equities show resilience amid rising job cuts and upcoming economic data releases.

2026-06-14 23:41; UTC

Geopolitical tensions and upcoming central bank meetings shape market sentiment as U.S. stocks show resilience and China's retail sales data raises concerns.

2026-06-14 23:41; UTC

Geopolitical tensions and the Bank of Japan's expected rate hike influence market sentiment, while U.S. stocks show resilience and Bitcoin rises amid economic volatility.

2026-06-14 23:41; UTC

Canada's Retail Sales Ex Autos Expected to Rise 0.7% in April Amid Cautious Economic Sentiment

2026-06-14 23:41; UTC

Correlated Moves
Macro News

The U.S. 30Y Treasury Bond Index is trading higher as easing geopolitical tensions from the U.S.-Iran peace deal boost market sentiment and investor confidence.

2026-06-14 23:31; UTC

China's House Price Index YoY release on June 16, 2026, faces cautious market sentiment amid ongoing declines and economic uncertainties.

2026-06-14 23:21; UTC

Philadelphia Fed Manufacturing Index Set for June 18 Release Amid Cautious Market Sentiment Following May's Unexpected Decline.

2026-06-14 23:11; UTC

GBP/NOK rises in after-market trading, supported by U.S. stock market resilience despite geopolitical tensions and inflation concerns. The asset remains above its 20-day moving average.

2026-06-14 23:11; UTC

U.S. Industrial Production MoM data for May 2026 set to release on June 15, with a modest growth forecast of 0.2% following April's strong performance amid geopolitical and supply chain concerns.

2026-06-14 23:11; UTC

EUR/NOK is trading higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

2026-06-14 23:02; UTC

Canada's New Housing Price Index set for June 17, with forecasts indicating a slight decline amid cautious market sentiment and ongoing government housing policy discussions.

2026-06-14 23:02; UTC

U.S. Retail Sales Ex Autos Expected to Rise 0.5% in June Amid Economic Uncertainty and Inflation Concerns

2026-06-14 23:02; UTC

U.S. Retail Sales Expected to Rise 0.5% in May Amid Economic Challenges and Consumer Confidence Concerns

2026-06-14 23:02; UTC

Correlated Moves

Gold/SGD is higher today, building on gains since Friday's close. The rise coincides with a notable increase in Silver prices.

2026-06-14 23:02; UTC

USD/HKD trading has been roughly flat after-market, showing little change since Friday's close. The asset remains in the middle of its one-month trading range.

2026-06-14 23:01; UTC

Macro News

USD/CNH declines in after-market trading amid geopolitical stability from the U.S.-Iran peace deal and ongoing G7 Summit discussions on economic policies.

2026-06-14 23:01; UTC

Gold and silver prices are lower in the current session, continuing a decline since Friday's close. Market sentiment may be influenced by upcoming Federal Reserve decisions.

2026-06-14 23:01; UTC

CHF/JPY is trading higher in after-market hours, continuing an upward trend since Friday's close. The pair remains near the lower end of its one-month range.

2026-06-14 23:01; UTC

Correlated Moves

Silver/SGD is higher today, continuing its upward trend alongside gold's gains. The asset peaked earlier with a cumulative return of 4.01%.

2026-06-14 23:01; UTC

Macro News

The FTSE 100 Index has advanced in after-market hours, supported by a U.S.-Iran peace deal that enhances navigation through the Strait of Hormuz.

2026-06-14 23:01; UTC

Correlated Moves

Gold/CHF is higher today, reflecting a broader increase in gold prices. The pair remains below its 20-day moving average, indicating unusual trading patterns.

2026-06-14 23:01; UTC

Correlated Moves
Macro News

Silver prices are rising amid geopolitical tensions and U.S.-Iran peace negotiations. Increased demand for safe-haven assets is driving the upward trend today.

2026-06-14 23:01; UTC

Macro News

Oil prices are lower as a U.S.-Iran peace deal eases tensions. Concerns about declining Cushing storage levels also weigh on the market.

2026-06-14 23:01; UTC

Macro News

The Nikkei 225 Index rose during after-market hours following a U.S.-Iran peace deal, easing geopolitical tensions and boosting investor sentiment.

2026-06-14 23:01; UTC

Correlated Moves

Gold/AUD is advancing, reflecting a broader upward trend in gold prices. The asset pulled back from a session high earlier in the session.

Akcijų palyginimas

Kainos pokytis

Corvus Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

164.88% į viršų

12 mėnesių prognozė

Vidutinis 31.6 USD  164.88%

Aukščiausias 40 USD

Žemiausias 27 USD

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Corvus Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

5 ratings

5

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers, T cell lymphomas, autoimmune, allergic, and infectious diseases. Its lead product candidate is soquelitinib (CPI-818), a selective covalent inhibitor of interleukin 2 inducible T cell kinase (ITK), which is in a multi-center Phase 1/1b clinical trial for the treatment of peripheral T cell lymphoma, solid tumors, and atopic dermatitis. The company is also developing ciforadenant (CPI-444), an oral small molecule antagonist of the A2A receptor that is in Phase 2 clinical trial for the treatment of metastatic renal cell cancer; and mupadolimab (CPI-006), a humanized monoclonal antibody, which is in Phase 1b clinical trial for the treatment of non-small cell lung cancer and head and neck cancer. In addition, it is developing CPI-182, an antibody designed to block inflammation and myeloid suppression that is in investigational new drug application-enabling studies, as well as CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a license afreemnt with Monash University to research, develop, and commercialize certain antibodies directed to CXCR2 for the treatment of human diseases; and Vernalis (R&D) Limited to develop, manufacture, and commercialize products containing certain adenosine receptor antagonists, including ciforadenant, as well as strategic collaboration with Angel Pharmaceuticals Co. Ltd. for the development and commercialization of mupadolimab. Corvus Pharmaceuticals, Inc. was incorporated in 2014 and is based in Burlingame, California.
help-icon Live chat